Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment

Inclusion Criteria: * Diagnosis of non-infectious intermediate, posterior, or pan- uveitis in at least one eye * Controlled uveitic disease in both eyes * Stable dose of oral corticosteroids in combination with selected stable immunosuppressive therapy * Effective contraceptive measures Exclusion Criteria: * Infectious uveitis and masquerade syndromes * Isolated anterior uveitis * Contraindication to mydriatics * Active tuberculosis disease * History of allergic or anaphylactic reactions to monoclonal antibodies * History of recurrent infection or predisposition to infection; active ocular infection * Pregnant or nursing women Other protocol-defined inclusion/exclusion criteria may apply